On the heels of making known its plan to buy ILEX Oncology Inc. for $1 billion, Genzyme Corp. has taken the lead-bidder position to buy the Physician Services unit of Impath Inc., which filed for bankruptcy in September and sold off another unit late last year. (BioWorld Today) Read More
